NCBiotech News

Burlington-based healthcare diagnostics company LabCorp has donated $1 million to Alamance Community College (ACC) to support the school’s growing biotechnology and life science curricula.

Fujifilm Corp. will expand its biomanufacturing facilities in Morrisville as part of a $90 million investment in its contract development and manufacturing organization (CDMO) business to meet growing customer demand for biopharmaceuticals.

Advanced Animal Diagnostics is “repurposing” its QScout animal blood test platform for use in humans, in the fight against COVID-19.

Brii Biosciences, a biopharmaceutical company with a Durham presence, is collaborating with Chinese scientists to discover, develop, manufacture and commercialize monoclonal antibodies to fight COVID-19.

Carolina Liquid Chemistries has introduced two new immunoassays to test for COVID-19 and for norfentanyl, the major metabolite of the synthetic opioid pain reliever fentanyl.

As the world grapples with a shortage of ventilators for COVID-19 patients, a small North Carolina life science startup has designed a low-cost option.

Q2 Solutions, a clinical trial laboratory services organization headquartered in Morrisville, has teamed up with the University of Texas Medical Branch to develop an assay for analyzing COVID-19 vaccine candidates.

Grifols, a global biotherapeutics company with more than 2,000 employees in North Carolina, will produce and test a potential COVID-19 therapy derived from the blood plasma of patients who have recovered from the coronavirus infection.

Heat Biologics, a publicly traded North Carolina biotechnology company, is adding a rapid point-of-care COVID-19 diagnostic test to its product development pipeline.

TARGET PharmaSolutions, a clinical data company based in Durham, has enrolled the first patient in a new observational study of how asthma patients are faring with various treatments for the disease.

Morrisville-based BioMedomics has partnered with BD to launch its new blood test for COVID-19 that can detect the infection within 15 minutes.

Charlotte's Bright Path Laboratories says it has found a better way to produce active pharmaceutical ingredients – those chemical components that make medicines work the way they’re supposed to.

There’s hope on the horizon for people struggling with the rare neurogenetic disorder Angelman syndrome, thanks to a newly formed partnership between AskBio and UNC.

NCCU has received a $330,000 grant to help the Department of Homeland Security predict and spot biological risks like the new coronavirus at the U.S. border.

Cary-based Lucerno Dynamics is improving quality control in nuclear medicine injections with its Lara System.